ADJUVANT STAGE 3 NEWS! ESMO SPAIN 2017

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. Content within the patient forum is user-generated and has not been reviewed by medical professionals. Other sections of the Melanoma Research Foundation website include information that has been reviewed by medical professionals as appropriate. All medical decisions should be made in consultation with your doctor or other qualified medical professional.

ADJUVANT STAGE 3 NEWS! ESMO SPAIN 2017

This topic has 7 replies, 4 voices, and was last updated 7 years, 8 months ago by geriakt.

Post

- September 11, 2017 at 9:14 pm
- Quote
SOLE
Participant
http://www.esmo.org/Oncology-News/Nivolumab-Bests-Ipilimumab-as-Adjuvant-Therapy-in-Resected-Melanoma

http://www.esmo.org/Oncology-News/Adjuvant-Dabrafenib-Plus-Trametinib-Significantly-Lowers-Risk-of-Death-in-Stage-III-BRAF-V600-Mutated-Melanoma

This is by far the most hopeful news I have seen this past year. This is a game changer for BRAF mutants AND for all of Stage 3 melanoma patients!

I hope all countries change their melanoma oncology practices ASAP!

Personally, I am not holding my breath for us Canadians. I will nonetheless try my luck with my oncologist, even if I am a year out in the clear (but still waiting confirmation on PET/CT next month…). And despite how pharmaceuticals companies design their clinical trials with the 12 week post operative period, I will try to get this one way or another.

Viewing 2 reply threads

Replies

- - September 11, 2017 at 11:35 pm
  - Quote
  ed williams
  Participant
  Good luck Sole, if you use Ipi/Nivo for stage 4 as an example in Canada you might be waiting 2 or 3 years for approval but not $$$ paid for!!!! Clinical trials are still the best way to get access in Canada from my experience. Best Wishes!!!Ed
  - September 12, 2017 at 2:12 am
    
    Quote
    SOLE
    Participant
    
    I wish I could get into ANY trial Ed. Unfortunately, my low genetic platelet condition prevents me from being able to!
- - September 12, 2017 at 12:24 am
  - Quote
  MovingOn
  Participant
  This may actually be the reason we've heard of patients getting even higher prices for Ipilimumab recently. If Nivo fully replaces Ipi then Bristol Myers will probably try to get as much as they can for the short remaining lifetime of Ipi.
  - September 12, 2017 at 12:25 am
    
    Quote
    MovingOn
    Participant
    
    Even though both drugs are from Bristol Myers.
- - September 12, 2017 at 1:20 am
  - Quote
  geriakt
  Participant
  I am a patient on this study. I believe I was given NIVO. Still going strong 2 years NED stage 3B.
  
  Tom
  - September 12, 2017 at 2:13 am
    
    Quote
    SOLE
    Participant
    
    Still on Nivo? I guess not. You got a full year of it, right?
  - September 12, 2017 at 5:24 pm
    
    Quote
    geriakt
    Participant
    
    I have been done just about one year now. Yes I had 34 infusions.

Viewing 2 reply threads

You must be logged in to reply to this topic.

The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.

The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.